Schneider's first rank symptoms \(1\)

More documents

Recommendations

Info

Oral vs Depot • Oral: •Depot: • First-pass metabolism • Variable bioavailability • Solves the problem of drug compliance • No <strong>first</strong>-pass effect • Decrease relapse rate • Once every 4 weeks (2 weeks for Risperdal Consta)
Depot antipsychotics • Modecate depot (fluphenazine decanoate) • Clopixol depot (zuclopenthixol decanoate) • Fluanxol depot (flupentixol decanoate) • Haldol depot (haloperidol decanoas) • Risperdal Consta
Page 1 and 2: Schizophrenia Dr. Edwin CS Yu Consu
Page 3 and 4: Aetiology (1) Genetics: Relationshi
Page 5 and 6: Aetiology (3) Personality: • Schi
Page 7 and 8: Clinical picture
Page 9 and 10: Schneider’s first rank symptoms (
Page 11 and 12: Hallucinations Auditory hallucinati
Page 13 and 14: Delusions (2) • Delusion of perse
Page 15 and 16: Disorders of affect • Blunted aff
Page 17 and 18: Negative symptoms • Chronic • P
Page 19 and 20: Onset • Variable modes of onset
Page 21 and 22: Good prognostic factors • Evidenc
Page 23 and 24: Long-term outcome • Tendency to r
Page 25 and 26: Post-schizophrenic depression (1)
Page 27 and 28: Drug treatment of schizophrenia Neu
Page 29 and 30: Drug treatment • Continuous thera
Page 31 and 32: Typical antipsychotics • Choose t
Page 33 and 34: Atypical antipsychotics • Most of
Page 35: Clozapine • Clozapine is a unique
Page 39 and 40: As general practitioners, it is imp
Page 41 and 42: Non-neurological S/E (2) Adverse Re
Page 43 and 44: Acute dystonia (1) Presentation Aff
Page 45 and 46: Parkinsonism (1) Feature Posture :
Page 47 and 48: Akathisia Feature Anxious, tense ex
Page 49 and 50: Tardive Dyskinesia (2) Presentation

Schneider's first rank symptoms \(1\)

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?